Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: Effect of induction by rifampin and ethnicity

Katarzyna K. Loboz(The University of Sydney), Andrew J. McLachlan(The University of Sydney), Ulrich M. Zanger(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Annette S. Gross(Emory University), Richard O. Day(St Vincent's Hospital Sydney), Winston Liauw(St George Hospital), Kenneth Williams(Johns Hopkins University), Julia Blievernicht(UNSW Sydney)
Clinical Pharmacology & Therapeutics
July 1, 2006
10.1016/j.clpt.2006.03.010
Cited by 98

Related Papers

Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
|Journal of Clinical Epidemiology|2012|1.2k
Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials
|BMJ|2015|577
Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis
|BMJ Open|2016|527
Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies
|Thrombosis and Haemostasis|2014|467
Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib
|Clinical Pharmacokinetics|2000|424